Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers

NCT03805984 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Lassa Fever

Interventions

DRUG: INO-4500
DRUG: Placebo
DEVICE: CELLECTRA® 2000

Sponsor

Inovio Pharmaceuticals

Collaborators

[object Object]